Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Perkins

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 26, 2003
Redox-controllable amphiphilic [2]rotaxanesHsian-Rong Tseng, Scott A Vignon, Paul C Celestre, et al.
International Journal of Oncology|September 6, 2007
Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphomaGerald L DeNardo, Saphon Hok, Arutselvan Van Natarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemiaRod Balhorn, Saphon Hok, Patricia A Burke, et al.
American Journal of Nephrology|March 20, 2004
Serum protein profile alterations in hemodialysis patientsRichard G Langlois, James E Trebes, Enrique A Dalmasso, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 26, 2003
Redox-controllable amphiphilic [2]rotaxanesHsian-Rong Tseng, Scott A Vignon, Paul C Celestre, et al.
International Journal of Oncology|September 6, 2007
Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphomaGerald L DeNardo, Saphon Hok, Arutselvan Van Natarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemiaRod Balhorn, Saphon Hok, Patricia A Burke, et al.
American Journal of Nephrology|March 20, 2004
Serum protein profile alterations in hemodialysis patientsRichard G Langlois, James E Trebes, Enrique A Dalmasso, et al.
Pageof 3